Skip to main content

Jonah Comstock

By Jonah Comstock | 12:38 pm | July 28, 2015
A Junto Health working group meets at the last team summit.
By Jonah Comstock | 09:46 am | July 27, 2015
The National Cybersecurity Center of Excellence (NCCoE), a division of the National Institute of Standards and Technology (NIST) has penned a five-part draft guidance on cybersecurity for mobile devices that connect to electronic health records.
By Jonah Comstock | 06:36 am | July 27, 2015
HelpAround, the Israel-based startup that raised $550,000 last year to bring the sharing economy to diabetes care, has launched a new app, Alert, which uses HealthKit data in realtime to provide support to patients.
By Jonah Comstock | 06:30 am | July 27, 2015
Just over half of ambulatory practice physicians (52 percent) use a mobile device to access patient records or reference data according to a new survey of more than 6,000 physicians from Black Book Market Research.
By Jonah Comstock | 06:24 pm | July 26, 2015
Physicians Interactive (PI), the digital health marketing company that offers medical reference apps and resources like Omnio to physicians, has acquired Waltham, Massachusetts-based Quantia Communications, parent company of physician social network QuantiaMD.
By Jonah Comstock | 10:45 am | July 22, 2015
Madison, Wisconsin-based Propeller Health has secured two new FDA clearances for new sensors that are designed to work with two particular inhalers on the market: the Diskus inhaler from GlaxoSmithKline and the Respimat inhaler from Boehringer Ingelheim.
By Jonah Comstock | 08:35 am | July 22, 2015
The regulatory battles for telemedicine continue to play out slowly in state legislatures across the country.
By Jonah Comstock | 11:44 am | July 20, 2015
Forty-one percent of consumers have never heard of telemedicine, according to a new survey of 1,200 consumers conducted by Survey Sampling International on behalf of HealthMine.
By Jonah Comstock | 11:22 am | July 20, 2015
Palo Alto-based novel blood test company Theranos was granted a waiver from the FDA allowing the company to offer its first FDA-cleared blood test, its herpes simplex 1 virus IgG (HSV IgG) test, outside of a lab setting.